India Globalization Capital (AMEX:IGC) shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC.
The company was issued a patent from the United States Patent And Trademark Office titled ‘Ultra-Low Dose THC As A Potential Therapeutic And Prophylactic Agent For Alzheimer’s Disease.’
India Globalization Capital purchases and resells physical infrastructure commodities. The company operates through two segments: Infrastructure Business and Life Sciences. The company operates in the United States, India, Columbia and Hong Kong.
The stock has a 52-week low of $0.54 and a 52-week high of $4.65.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
